艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

休市中 09-04 16:00:00 EDT

256.46

-3.75

-1.44%

盘后256.53

+0.07+0.03%

19:59 EDT

最高258.91	最低255.58	成交量472.98万
今开257.96	昨收260.21	日振幅1.28%
总市值4,533亿	流通市值4,521亿	总股本17.67亿
成交额12.14亿	换手率0.27%	流通股本17.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":256.46,"timestamp":1788552000000,"preClose":260.21,"halted":0,"volume":4729800,"hourTrading":{"tag":"盘后","latestPrice":256.533,"preClose":256.46,"latestTime":"19:59 EDT","volume":353512,"amount":90671206.02252,"timestamp":1788566343019,"change":0.073,"changeRate":0.000285,"amplitude":0.006239},"delay":0,"changeRate":-0.014411436916336806,"floatShares":1762950764,"shares":1767384632,"eps":3.539701,"marketStatus":"休市中","change":-3.75,"latestTime":"09-04 16:00:00 EDT","open":257.96,"high":258.91,"low":255.58,"amount":1213788235.86,"amplitude":0.012797,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.539701,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":260.21,"dividendRate":0.026632,"preHourTrading":{"tag":"盘前","latestPrice":257.2,"preClose":260.21,"latestTime":"09:29 EDT","volume":3129,"amount":807048.73305,"timestamp":1788528589416,"change":-3.01,"changeRate":-0.011568,"amplitude":0.01103},"postHourTrading":{"tag":"盘后","latestPrice":256.533,"preClose":256.46,"latestTime":"19:59 EDT","volume":353512,"amount":90671206.02252,"timestamp":1788566343019,"change":0.073,"changeRate":0.000285,"amplitude":0.006239},"volumeRatio":1.27754,"optionData":{"bulkOrders":[{"symbol":"ABBV","call":false,"expireDate":1797570000000,"strike":"240.0","timestamp":1788534315697,"price":7.95,"volume":1500,"amount":1192500,"type":"*"}]},"impliedVol":0.2767,"impliedVolPercentile":0.4127},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"2664388058","title":"109亿美元重磅收购Apogee(APGE.US)落地！艾伯维(ABBV.US)完成2019年以来最大并购，预计2032年起贡献收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664388058?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B19Z3B42.SGD","PJP","JDOC","TRUH","LU0124676726.USD","LU2129689605.HKD","SG9999003800.SGD","LU1267930490.SGD","ABBV","XLV","SBIO","IE0002141913.USD","APGE","LU1839511570.USD","PPH","CALF","LU1551013425.SGD","LU0320765646.SGD","LU0170899867.USD","LU1496350502.SGD","IXJ","LU0128525929.USD","BK4533","IE000WAW04H5.SGD","LU2087621335.USD","LU2089984988.USD","XMMO","MYLD","VHT","LU1236620834.HKD","LU0820561909.HKD","FTXH","RXL","LU2237443895.HKD","KCE","LU0203345920.USD","LU0859254822.USD","LU0114720955.EUR","LU2129689514.USD","AGNG","MEDX","IYH","LU0069063385.USD","LU2125909593.SGD","LU2433249047.HKD","GLAM","FHLC","LU0234570918.USD","LU0310800379.SGD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664053388","title":"109亿美元重磅收购Apogee(APGE.US)落地！艾伯维(ABBV.US)完成2019年以来最大并购，预计2032年起贡献收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664053388","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664053388?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维于周四表示，公司已完成对抗炎药物研发商 Apogee Therapeutics价值 109 亿美元的收购。笔交易是这家制药巨头自 2019 年以来规模最大的补强型收购，智通财经AAPP于今年 6 月首次对此进行了报道。艾伯维预计，该项收购将对其调整后稀释每股收益产生负面影响，其中 2026 年将减少 0.14 美元，2027 年减少约 0.46 美元，并预计将于 2032 年开始实现增益。该指引已包含与完成 Apogee 收购相关的每股 0.14 美元稀释效应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4559","LU1934455194.USD","KCE","LU1718418525.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IXJ","LU0124676726.USD","IYH","APGE","XMMO","BK4566","LU1989772840.SGD","PJP","AGNG","SG9999011175.SGD","ABBV","VHT","LU0965509283.SGD","LU0170899867.USD","IE00BLSP4239.USD","IE0002270589.USD","CALF","LU1003077747.HKD","FHLC","LU0289739343.SGD","LU2089283258.USD","IE00BN8TJ469.HKD","LU1037948541.HKD","BK4581","TRUH","LU0203345920.USD","IE0004445239.USD","LU0985320562.USD","MEDX","LU1983299246.USD","FTXH","JDOC","GLAM","XLV","SBIO","LU0256863902.USD","LU2237443549.SGD","PPH","RXL","IE00B19Z3581.USD","LU0057025933.USD","MYLD","LU1093756168.USD","LU1236620834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112455320","title":"艾伯维公布Cervino三期试验积极顶线结果：Etentamig显著提升复发/难治性多发性骨髓瘤患者缓解率与无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1112455320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112455320?lang=zh_cn&edition=full","pubTime":"2026-09-03 21:19","pubTimestamp":1788441558,"startTime":"0","endTime":"0","summary":"艾伯维公司今日宣布，其针对复发或难治性多发性骨髓瘤患者的关键性Cervino三期临床试验，取得了积极的顶线数据。研究结果显示，在研药物Etentamig不仅显著提高了患者的客观缓解率，更在延长无进展生存期方面展现出压倒性的统计学优势。Cervino试验是一项全球性的、随机、开放标签的注册研究，旨在评估Etentamig相较于标准治疗的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU0128525929.USD","LU0738911758.USD","LU1093756325.SGD","LU1989771016.USD","MEDX","LU0965509101.SGD","LU0795875169.SGD","IE00BJT1NW94.SGD","LU1074936037.SGD","LU1291159041.SGD","LU0417517546.SGD","LU0942090050.USD","LU1732800096.USD","IE00BVYPNV92.GBP","LU0943347566.SGD","FTXH","IE000SO60NU8.SGD","LU1585245621.USD","LU2237443382.USD","LU2468319806.SGD","LU1430594728.SGD","ABBV","LU2129689431.USD","LU2023251221.USD","LU0029864427.USD","LU0820561818.USD","LU1718418525.SGD","LU0256863902.USD","GLAM","LU1023059063.AUD","LU0289961442.SGD","LU0203345920.USD","LU0708994859.HKD","LU1267930490.SGD","IE00B2B36J28.USD","AGNG","IE0002270589.USD","LU0211327993.USD","LU2112291526.USD","IXJ","BK4581","LU0058720904.USD","LU1670628061.USD","VHT","LU0289739699.SGD","LU0545039389.USD","LU0395794307.EUR","JDOC","BK4139","LU2237443895.HKD","LU0114720955.EUR","LU0795875086.SGD","LU1934455194.USD","LU1923622614.USD","IE00BLSP4452.SGD","LU2129689514.USD","LU1989772840.SGD","SG9999011175.SGD","LU2237443465.HKD","SG9999015952.SGD","LU2347655156.SGD","BK4534","LU2237443622.USD","LU2433249047.HKD","IE00BBT3K403.USD","LU1061106388.HKD","TRUH","LU0965509010.AUD","LU0456855351.SGD","IE00BN8TJ469.HKD","LU0689626769.HKD","SG9999015986.USD","IE0004445239.USD","LU1236620834.HKD","IE000WAW04H5.SGD","LU2237443549.SGD","LU1003077747.HKD","BK4566","IE000MB6IJN5.SGD","LU0124676726.USD","LU1244550494.USD","LU1551013342.USD","LU0949170772.SGD","LU1037948541.HKD","LU1057294990.SGD","LU2087621335.USD","PPH","LU0861579265.USD","LU1244550221.USD","LU0122379950.USD","IE00BDGV0183.EUR","LU1929549753.HKD","LU0069063385.USD","FHLC","LU0057025933.USD","IE00BVYPNW00.USD","LU1983299246.USD","IE0002141913.USD","LU2125909247.SGD","LU1236620750.USD","LU2129689605.HKD","IE00B19Z3B42.SGD","LU2237443978.SGD","LU0289739343.SGD","LU0726765562.USD","LU2089283258.USD","BK4559","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU2125909593.SGD","LU0472753341.HKD","LU0203347892.USD","LU0198837287.USD","BK4588","LU1244550577.SGD","LU2089984988.USD","LU0310800379.SGD","LU0823416689.USD","LU1496350171.SGD","SG9999003800.SGD","LU0985320562.USD","LU0211328371.USD","LU1093756168.USD","LU1989772923.USD","LU1162221912.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU1496350502.SGD","LU1839511570.USD","BK4533","IYH","LU1934455863.HKD","LU1551013425.SGD","IE00BLSP4239.USD","LU0661504455.SGD","LU0912757837.SGD","SG9999015978.USD","IE00BGHQF631.EUR","RXL","IE000BZT7R73.USD","SG9999015945.SGD","LU1037948897.HKD","LU0689472784.USD","PJP","BK4585","LU0859254822.USD","IE0000B7K699.USD","LU1267930573.SGD","BK4550","LU0098860793.USD","LU0310799852.SGD","LU2357627491.SGD","IE00B3PB1722.GBP","LU1934455277.USD","LU2347655073.USD","LU0234570918.USD","LU0158827948.USD","LU1670627923.USD","LU0234572021.USD","LU0511384066.AUD","LU0965508806.USD","LU0432979614.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0256863811.USD","LU0320765646.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","LU1732799900.SGD","IE000F7OJYX1.SGD","LU0868494708.USD","LU2133065610.SGD","XLV","LU0170899867.USD","LU0820561909.HKD","LU0965509283.SGD","IE00B42XCP33.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169611288","title":"FDA：不会启动撤销仿制药批准的流程——这些仿制药参照的是Namenda产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1169611288","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169611288?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:55","pubTimestamp":1788180909,"startTime":"0","endTime":"0","summary":"根据《联邦公报》发布的信息，美国食品药品监督管理局（FDA）宣布，将不会启动撤销相关简化新药申请（ANDA）批准的程序。这些申请所参照的，正是涉及Namenda系列产品的上市申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU2089984988.USD","FTXH","LU2129689514.USD","IE0002141913.USD","LU1496350502.SGD","IE00BJT1NW94.SGD","LU1162221912.USD","LU0545039389.USD","LU0289739699.SGD","BK4139","SG9999015986.USD","IE00B3PB1722.GBP","LU0234572021.USD","LU0942090050.USD","LU0456855351.SGD","LU0795875169.SGD","LU0859254822.USD","IE0000B7K699.USD","LU1003077747.HKD","BK4585","LU1236620750.USD","IE000BZT7R73.USD","LU0098860793.USD","SG9999015952.SGD","TRUH","LU0726765562.USD","LU0820561818.USD","IE0002270589.USD","SG9999015945.SGD","BK4588","LU0820561909.HKD","LU0234570918.USD","LU0417517546.SGD","BK4581","LU0124676726.USD","LU0985320562.USD","LU2347655156.SGD","PPH","LU1551013342.USD","IE000WAW04H5.SGD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU1551013425.SGD","LU0689626769.HKD","LU1670628061.USD","LU2125909593.SGD","LU1037948541.HKD","SG9999003800.SGD","IE00B19Z3581.USD","IE00B42XCP33.USD","ABBV","FHLC","LU0661504455.SGD","LU0289961442.SGD","RXL","IXJ","LU2237443382.USD","LU0949170772.SGD","LU1267930490.SGD","LU0432979614.USD","LU2237443465.HKD","LU1093756168.USD","IE00BLSP4239.USD","SG9999011175.SGD","LU2129689605.HKD","IE000F7OJYX1.SGD","LU1585245621.USD","LU2112291526.USD","LU0310799852.SGD","LU0553294199.USD","IE00BGHQF631.EUR","LU0965509010.AUD","LU1718418525.SGD","LU1989772923.USD","SG9999015978.USD","IE00BSNM7G36.USD","GLAM","IE00B4R5TH58.HKD","LU0114720955.EUR","LU0882574055.USD","LU1244550577.SGD","LU1023059063.AUD","LU0795875086.SGD","LU1923622614.USD","LU0310800379.SGD","LU0203345920.USD","LU1934455277.USD","LU0203347892.USD","LU1244550494.USD","IE00BVYPNV92.GBP","LU0943347566.SGD","LU2237443622.USD","LU1244550221.USD","LU0689472784.USD","LU0158827948.USD","BK4534","IE000SO60NU8.SGD","LU1934455863.HKD","LU2237443895.HKD","AGNG","LU0861579265.USD","LU1732799900.SGD","IE00BBT3K403.USD","LU1670627923.USD","IE00BFTCPJ56.SGD","LU0320765646.SGD","LU0868494617.USD","LU1074936037.SGD","IE0009355771.USD","LU0965508806.USD","LU2089284900.SGD","LU0256863811.USD","LU1236620834.HKD","IE00BVYPNW00.USD","XLV","IE00B2B36J28.USD","LU1983299246.USD","LU2433249047.HKD","LU0472753341.HKD","LU0058720904.USD","LU0170899867.USD","VHT","LU0069063385.USD","LU1732800096.USD","IE00BJJMRZ35.SGD","LU0029864427.USD","LU0868494708.USD","JDOC","LU2125909247.SGD","LU2237443549.SGD","LU2087621335.USD","BK4566","IE0004445239.USD","LU0395794307.EUR","IE00B19Z3B42.SGD","LU1057294990.SGD","LU0256863902.USD","BK4550","LU0198837287.USD","LU2347655073.USD","PJP","LU2237443978.SGD","LU1037948897.HKD","LU0057025933.USD","LU0289739343.SGD","LU1267930573.SGD","LU2129689431.USD","LU2023251221.USD","LU1989771016.USD","LU1989772840.SGD","IE000MB6IJN5.SGD","SG9999001440.SGD","LU0122379950.USD","LU2357627491.SGD","LU0211327993.USD","LU1291159041.SGD","LU0823416689.USD","BK4533","LU2468319806.SGD","IE00BLSP4452.SGD","LU0708994859.HKD","LU0912757837.SGD","LU0511384066.AUD","LU0211328371.USD","LU1496350171.SGD","LU1934455194.USD","IYH","LU1929549753.HKD","LU0965509101.SGD","LU2089283258.USD","LU1839511570.USD","LU1061106388.HKD","LU1093756325.SGD","MEDX","BK4559","LU0128525929.USD","LU0738911758.USD","LU2133065610.SGD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639772","title":"伯维（ABBV）向EMA递交Skyrizi克罗恩病治疗上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639772","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662639772?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:56","pubTimestamp":1787821007,"startTime":"0","endTime":"0","summary":"Skyrizi此前已经在银屑病、银屑病关节炎等多个自身免疫疾病领域拿到欧洲地区的获批资质，如若本次克罗恩病适应症顺利获批，将进一步拓宽该产品在欧洲炎症性肠病赛道的市场空间。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","RXL","LU0661504455.SGD","PPH","AGNG","IPOS","LU1989771016.USD","LU2087621335.USD","MEDX","IXJ","LU0058720904.USD","PJP","EMA","VHT","FHLC","LU0289739699.SGD","LU1267930573.SGD","LU2125909247.SGD","LU1236620750.USD","LU0417517546.SGD","JDOC","LU0114720955.EUR","FTXH","BK4559","LU2089283258.USD","LU1585245621.USD","SG9999001440.SGD","SG9999011175.SGD","LU2125909593.SGD","ABBV","LU0472753341.HKD","LU0234572021.USD","LU0198837287.USD","LU2023251221.USD","LU0965508806.USD","LU2237443622.USD","LU0882574055.USD","LU1732799900.SGD","TRUH","LU0985320562.USD","GLAM","IE000F7OJYX1.SGD","LU1839511570.USD","LU2133065610.SGD","XLV","BK4533","IYH","IE0004445239.USD","LU1236620834.HKD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195775229","title":"艾伯维向欧洲药品管理局提交Skyrizi®（瑞莎珠单抗）皮下诱导治疗申请，针对中重度活动性克罗恩病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1195775229","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195775229?lang=zh_cn&edition=full","pubTime":"2026-08-27 14:00","pubTimestamp":1787810433,"startTime":"0","endTime":"0","summary":"艾伯维公司已正式向欧洲药品管理局递交了一项监管申请，旨在寻求Skyrizi皮下注射剂型的上市许可。该申请针对的适应症为——用于治疗患有中重度活动性克罗恩病的成年患者，且此方案将作为诱导治疗手段。若此次申请获得批准，Skyrizi的皮下给药方式将为患者提供更为便捷的治疗选择，有望改善治疗依从性与患者体验。此次针对克罗恩病皮下诱导治疗的申请，进一步丰富了Skyrizi的潜在临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","IE000BZT7R73.USD","LU2237443465.HKD","LU0310800379.SGD","LU0456855351.SGD","LU1037948897.HKD","LU0417517546.SGD","LU1989771016.USD","IE0002141913.USD","LU1923622614.USD","IXJ","LU1496350171.SGD","LU2129689431.USD","LU0395794307.EUR","LU2357627491.SGD","LU0203345920.USD","LU0289739343.SGD","LU2237443549.SGD","SG9999003800.SGD","LU0942090050.USD","LU2112291526.USD","LU0158827948.USD","IE0009355771.USD","JDOC","LU0098860793.USD","LU0128525929.USD","LU0661504455.SGD","LU0820561909.HKD","LU2133065610.SGD","LU0823416689.USD","IE00B19Z3B42.SGD","BK4559","LU1989772923.USD","LU2089984988.USD","LU1929549753.HKD","LU0868494617.USD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","LU0795875169.SGD","LU1236620834.HKD","LU1003077747.HKD","VHT","LU1244550221.USD","LU2433249047.HKD","LU2125909247.SGD","LU1162221912.USD","LU2347655156.SGD","LU1670627923.USD","RXL","LU0256863811.USD","LU1430594728.SGD","GLAM","LU0058720904.USD","LU2237443382.USD","SG9999015952.SGD","LU0029864427.USD","IE00BSNM7G36.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU0211328371.USD","IE00B19Z3581.USD","SG9999015978.USD","LU0689472784.USD","LU1267930573.SGD","BK4533","LU0738911758.USD","ABBV","IE00BVYPNV92.GBP","LU2468319806.SGD","BK4588","LU0069063385.USD","LU1934455863.HKD","BK4566","LU2237443895.HKD","LU1093756168.USD","LU1061106388.HKD","LU1496350502.SGD","LU1585245621.USD","LU1983299246.USD","LU0310799852.SGD","IE00BVYPNW00.USD","LU0289739699.SGD","LU0795875086.SGD","LU1267930490.SGD","LU1934455194.USD","LU0170899867.USD","LU0965508806.USD","IE0002270589.USD","LU1989772840.SGD","LU1093756325.SGD","LU1718418525.SGD","SG9999011175.SGD","BK4534","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","LU2347655073.USD","LU1670628061.USD","LU0912757837.SGD","IE0000B7K699.USD","LU0234572021.USD","LU0256863902.USD","LU0943347566.SGD","IE00BBT3K403.USD","LU2089284900.SGD","XLV","LU1732800096.USD","IE0004445239.USD","LU0949170772.SGD","LU1551013342.USD","IE00BLSP4452.SGD","LU0114720955.EUR","LU0553294199.USD","LU0882574055.USD","IE00B4R5TH58.HKD","LU1244550494.USD","LU0965509283.SGD","LU2089283258.USD","LU1037948541.HKD","LU1934455277.USD","SG9999001440.SGD","IE000WAW04H5.SGD","FTXH","LU2023251221.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0859254822.USD","LU1244550577.SGD","LU1839511570.USD","TRUH","IE00B42XCP33.USD","LU0211327993.USD","LU0708994859.HKD","PPH","LU0289961442.SGD","LU0726765562.USD","MEDX","SG9999015945.SGD","LU0985320562.USD","LU2129689514.USD","BK4550","BK4139","LU0124676726.USD","LU0965509010.AUD","LU0511384066.AUD","LU0689626769.HKD","LU1074936037.SGD","IE000SO60NU8.SGD","LU2125909593.SGD","LU0122379950.USD","LU0198837287.USD","IYH","LU1057294990.SGD","SG9999015986.USD","LU2237443978.SGD","LU0820561818.USD","AGNG","LU0057025933.USD","LU0472753341.HKD","LU1291159041.SGD","LU0965509101.SGD","PJP","IE000MB6IJN5.SGD","LU0545039389.USD","LU2237443622.USD","FHLC","IE00B3PB1722.GBP","LU2129689605.HKD","LU1732799900.SGD","BK4581","LU0432979614.USD","BK4585","LU0234570918.USD","LU2087621335.USD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU1023059063.AUD","LU0861579265.USD","LU0203347892.USD","LU1236620750.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193640360","title":"异动解读｜艾伯维公司盘中上涨3.04%，多家投行密集上调目标价叠加管线催化延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1193640360","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193640360?lang=zh_cn&edition=full","pubTime":"2026-08-20 03:36","pubTimestamp":1787168214,"startTime":"0","endTime":"0","summary":"8月19日，艾伯维公司盘中上涨3.04%，报266.765美元/股，成交额8.13亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价：Wolfe将评级上调至\"跑赢大盘\"并给予300美元目标价，富国银行上调目标价至300美元维持增持，巴克莱上调至300美元，摩根大通上调至285美元，美银上调至276美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156251729","title":"异动解读｜艾伯维公司盘中上涨3.03%，多家投行上调目标价叠加管线催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1156251729","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156251729?lang=zh_cn&edition=full","pubTime":"2026-08-19 00:19","pubTimestamp":1787069954,"startTime":"0","endTime":"0","summary":"8月19日，艾伯维公司盘中上涨3.03%，报257.915美元/股，成交额4.05亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价。管线方面，艾伯维近日在ClinicalTrials平台登记了从荣昌生物引进的PD-1/VEGF双抗RC148全球III期临床试验，头对头对照帕博利珠单抗联合化疗用于一线非小细胞肺癌，标志着该资产进入后期开发阶段，进一步丰富公司肿瘤管线布局。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656597285","title":"艾伯维（ABBV）保妥适新适应症获FDA受理 有望成美国首款咬肌突出医美肉毒制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2656597285","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656597285?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:03","pubTimestamp":1785848630,"startTime":"0","endTime":"0","summary":"艾伯维表示，本次申报是对成熟产品潜力的进一步挖掘，以此匹配不断变化的求美者需求。作为医美赛道重磅单品，新适应症如若获批，有望进一步巩固艾尔建美学在注射医美领域的市场地位。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NmRmY2E4Njg2ODIwNjk0NjU5Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NmRmY2E4Njg2ODIwNjk0NjU5Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689605.HKD","JDOC","LU0820561818.USD","ABBV","LU0553294199.USD","TRUH","XLV","LU0795875169.SGD","LU0965509101.SGD","AGNG","SG9999015952.SGD","IE000MB6IJN5.SGD","LU0738911758.USD","MEDX","BK4588","LU0868494708.USD","IE00B2B36J28.USD","VHT","GLAM","IE000SO60NU8.SGD","LU0965509010.AUD","LU1989771016.USD","FTXH","LU0708994859.HKD","LU0942090050.USD","LU1989772923.USD","IXJ","LU0158827948.USD","LU2125909593.SGD","LU2089283258.USD","LU2433249047.HKD","PPH","LU0098860793.USD","LU2129689431.USD","RXL","LU1430594728.SGD","LU1496350502.SGD","IYH","SG9999015945.SGD","PJP","IE00B3PB1722.GBP","LU1670628061.USD","LU0289739699.SGD","IE000BZT7R73.USD","LU1989772840.SGD","LU1670627923.USD","LU0320765646.SGD","LABU","FHLC","LU0912757837.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175108203","title":"艾伯维三期临床研究达标：主要终点相较安慰剂实现统计学显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1175108203","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175108203?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:04","pubTimestamp":1785845057,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）宣布，其三期临床研究成功达成主要终点，与安慰剂相比，展现出统计学意义上的显著改善。这一结果标志着该药物研发进程中的关键里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","IE000BZT7R73.USD","LU2237443465.HKD","LU0310800379.SGD","LU0456855351.SGD","LU1037948897.HKD","LU0417517546.SGD","LU1989771016.USD","IE0002141913.USD","LU1923622614.USD","IXJ","LU1496350171.SGD","LU2129689431.USD","LU0395794307.EUR","LU2357627491.SGD","LU0203345920.USD","LU0289739343.SGD","LU2237443549.SGD","SG9999003800.SGD","LU0942090050.USD","LU2112291526.USD","LU0158827948.USD","IE0009355771.USD","JDOC","LU0098860793.USD","LU0128525929.USD","LU0661504455.SGD","LU0820561909.HKD","LU2133065610.SGD","LU0823416689.USD","IE00B19Z3B42.SGD","BK4559","LU1989772923.USD","LU2089984988.USD","LU1929549753.HKD","LU0868494617.USD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","LU0795875169.SGD","VHT","LU1003077747.HKD","LU1244550221.USD","LU2433249047.HKD","LU2125909247.SGD","LU1162221912.USD","LU2347655156.SGD","LU1670627923.USD","RXL","LU0256863811.USD","LU1430594728.SGD","GLAM","LU0058720904.USD","LU2237443382.USD","SG9999015952.SGD","LU0029864427.USD","IE00BSNM7G36.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU0211328371.USD","IE00B19Z3581.USD","SG9999015978.USD","LU0689472784.USD","LU1267930573.SGD","BK4533","LU0738911758.USD","ABBV","IE00BVYPNV92.GBP","LU2468319806.SGD","BK4588","LU0069063385.USD","LU1934455863.HKD","BK4566","LU2237443895.HKD","LU1093756168.USD","LU1061106388.HKD","LU1496350502.SGD","LU1585245621.USD","LU1983299246.USD","LU0310799852.SGD","IE00BVYPNW00.USD","LU0289739699.SGD","LU0795875086.SGD","LU1267930490.SGD","LU1934455194.USD","LU0170899867.USD","LU0965508806.USD","IE0002270589.USD","LU1989772840.SGD","LU1093756325.SGD","LU1718418525.SGD","SG9999011175.SGD","BK4534","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","LU2347655073.USD","LU1670628061.USD","LU0912757837.SGD","IE0000B7K699.USD","LU0234572021.USD","LU0256863902.USD","LU0943347566.SGD","IE00BBT3K403.USD","LU2089284900.SGD","XLV","LU1732800096.USD","IE0004445239.USD","LU0949170772.SGD","LU1551013342.USD","IE00BLSP4452.SGD","LU0114720955.EUR","LU0553294199.USD","LU0882574055.USD","IE00B4R5TH58.HKD","LU1244550494.USD","LU0965509283.SGD","LU2089283258.USD","LU1037948541.HKD","LU1934455277.USD","SG9999001440.SGD","IE000WAW04H5.SGD","FTXH","LU2023251221.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0859254822.USD","LU1244550577.SGD","LU1839511570.USD","TRUH","IE00B42XCP33.USD","LU0211327993.USD","LU0708994859.HKD","PPH","LU0289961442.SGD","LU0726765562.USD","MEDX","SG9999015945.SGD","LU0985320562.USD","LU2129689514.USD","BK4550","BK4139","LU0124676726.USD","LU0965509010.AUD","LU0511384066.AUD","LU0689626769.HKD","LU1074936037.SGD","IE000SO60NU8.SGD","LU2125909593.SGD","LU0122379950.USD","LU0198837287.USD","IYH","LU1057294990.SGD","SG9999015986.USD","LU2237443978.SGD","LU0820561818.USD","AGNG","LU0057025933.USD","LU0472753341.HKD","LU1291159041.SGD","LU0965509101.SGD","PJP","IE000MB6IJN5.SGD","LU0545039389.USD","LU2237443622.USD","FHLC","IE00B3PB1722.GBP","LU2129689605.HKD","LU1732799900.SGD","BK4581","LU0432979614.USD","BK4585","LU0234570918.USD","LU2087621335.USD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU1023059063.AUD","LU0861579265.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173570619","title":"艾伯维旗下艾尔建美学宣布：保妥适®美容（用于咬肌突出）补充生物制剂许可申请获美国FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1173570619","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173570619?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:02","pubTimestamp":1785844948,"startTime":"0","endTime":"0","summary":"艾伯维（AbbVie）旗下艾尔建美学（Allergan Aesthetics）今日正式对外宣告，其针对保妥适®美容（Botox® Cosmetic）用于改善咬肌突出问题的补充生物制剂许可申请（sBLA），已成功获得美国食品药品监督管理局（FDA）的受理。这一进展标志着该产品在拓展适应症领域迈出了关键一步，有望为相关需求人群提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU2237443549.SGD","XLV","IE0004445239.USD","IE00BVYPNW00.USD","LU0289739343.SGD","BK4585","LU0689472784.USD","SG9999015986.USD","LU0057025933.USD","BK4139","LU1989771016.USD","IE00BVYPNV92.GBP","LU1983299246.USD","LU0069063385.USD","LU1718418525.SGD","IE00B19Z3B42.SGD","SG9999015978.USD","LU2125909593.SGD","LU0203345920.USD","LU1023059063.AUD","LU1989772840.SGD","IYH","LU2089284900.SGD","LU2237443382.USD","LU0511384066.AUD","PPH","LU1244550494.USD","LU1037948541.HKD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","LU0234572021.USD","LU0122379950.USD","LU0795875086.SGD","LU1003077747.HKD","IE0000B7K699.USD","LU0395794307.EUR","MEDX","LU0170899867.USD","LU0726765562.USD","LU1934455863.HKD","FHLC","LU1732800096.USD","LU1929549753.HKD","IE000F7OJYX1.SGD","BK4588","SG9999003800.SGD","LU0114720955.EUR","LU0124676726.USD","LU0320765646.SGD","LU0417517546.SGD","BK4533","LU2125909247.SGD","AGNG","LU0234570918.USD","LU2129689605.HKD","IE00BSNM7G36.USD","IE0002141913.USD","LU0965509283.SGD","LU1670628061.USD","LU2433249047.HKD","LU1934455194.USD","LU1989772923.USD","IE00BJT1NW94.SGD","SG9999015952.SGD","LU0456855351.SGD","FTXH","IE00BN8TJ469.HKD","LU2089984988.USD","LU0820561818.USD","LU1291159041.SGD","LU0432979614.USD","LU1430594728.SGD","LU2129689431.USD","LU0098860793.USD","LU0823416689.USD","LU0545039389.USD","GLAM","LU1244550221.USD","IE00BFTCPJ56.SGD","LU1267930573.SGD","IE00B19Z3581.USD","LU2112291526.USD","LU1037948897.HKD","LU0942090050.USD","LU0029864427.USD","BK4550","LU0661504455.SGD","IE000MB6IJN5.SGD","IE00B3PB1722.GBP","LU0289739699.SGD","LU1496350171.SGD","LU0882574055.USD","LU1839511570.USD","IE000BZT7R73.USD","LU0058720904.USD","LU1732799900.SGD","SG9999001440.SGD","LU1670627923.USD","LU0689626769.HKD","LU0820561909.HKD","LU0985320562.USD","LU0256863811.USD","LU0158827948.USD","LU1496350502.SGD","LU1551013342.USD","JDOC","LU2237443622.USD","LU0868494708.USD","IE00BDGV0183.EUR","LU1093756325.SGD","LU0211328371.USD","LU1551013425.SGD","LU1244550577.SGD","RXL","LU1162221912.USD","BK4559","BK4566","IE00BGHQF631.EUR","SG9999015945.SGD","LU0861579265.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1934455277.USD","LU2237443465.HKD","LU1057294990.SGD","TRUH","LU2347655156.SGD","LU0310800379.SGD","IE00B2B36J28.USD","LU0949170772.SGD","LU0203347892.USD","LU0289961442.SGD","LU0859254822.USD","LU1267930490.SGD","LU0943347566.SGD","LU2129689514.USD","LU1093756168.USD","LU2023251221.USD","LU2237443895.HKD","SG9999011175.SGD","LU0310799852.SGD","VHT","BK4581","LU0965509101.SGD","IE0002270589.USD","IE00B42XCP33.USD","LU0472753341.HKD","LU0912757837.SGD","LU1585245621.USD","PJP","IE00B4R5TH58.HKD","IE00BBT3K403.USD","LU0256863902.USD","LU1923622614.USD","LU0795875169.SGD","LU0965509010.AUD","LU1074936037.SGD","LU2237443978.SGD","LU1061106388.HKD","IE0009355771.USD","LU0708994859.HKD","ABBV","LU0738911758.USD","LU0198837287.USD","LU2347655073.USD","LU2357627491.SGD","LU0211327993.USD","LU0965508806.USD","LU2468319806.SGD","IXJ","LU2133065610.SGD","BK4534","LU2087621335.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","IE00BLSP4452.SGD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107633372","title":"异动解读｜艾伯维公司盘中下跌3.04%，Q2业绩超预期但全年盈利指引因收购摊薄下调","url":"https://stock-news.laohu8.com/highlight/detail?id=1107633372","media":"行情直击","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107633372?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:04","pubTimestamp":1785506697,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘中下跌3.04%，报251.87美元/股，成交额3.18亿美元。然而，公司将全年调整后每股收益指引下调至13.87至14.07美元，低于此前的13.91至14.11美元，亦低于市场预期的14.06美元。指引下调主要源于收购Apogee Therapeutics带来的每股约0.14美元摊薄影响，以及第二季度计入的2.91亿美元IPR&D费用对每股收益造成的0.17美元拖累。业绩兑现后，市场对全年盈利前景的担忧触发获利回吐。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154857507","title":"艾伯维Q2业绩超预期，Skyrizi与Rinvoq表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1154857507","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154857507?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:37","pubTimestamp":1785505047,"startTime":"0","endTime":"0","summary":"摩根大通分析师在最新研究报告中指出，艾伯维公司第二季度财报业绩超出市场预期。营收超预期表现颇为广泛——其中，Skyrizi和Rinvoq这两款药物的销售数据均小幅超过预估。分析师补充道：\"在接下来的业绩电话会上，我们将密切关注两大核心议题：其一，Skyrizi和Rinvoq的市场渗透率是否出现变化，以及针对这两款药物的最新业绩指引；其二，关于业务拓展方面的战略表态。\"值得注意的是，艾伯维在早盘交易中下跌1%。此前，该公司下调了全年调整后盈利预期，主要归因于其对Apogee Therapeutics的收购交易。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU0738911758.USD","LU0553294199.USD","LU2112291526.USD","LU2129689514.USD","IE00B2B36J28.USD","LU0861579265.USD","LU1291159041.SGD","LU1244550577.SGD","IE0004445239.USD","IE0009355771.USD","LU2129689431.USD","LU1929549753.HKD","LU0058720904.USD","IE00B19Z3581.USD","ABBV","LU0069063385.USD","LU1551013342.USD","LU1267930573.SGD","LU2347655073.USD","LU0211328371.USD","BK4581","BK4533","IE000SO60NU8.SGD","LU0198837287.USD","LU1496350171.SGD","LU0128525929.USD","LU2087621335.USD","IE00BVYPNV92.GBP","IE00BJT1NW94.SGD","FTXH","LU0456855351.SGD","IE000MB6IJN5.SGD","IE0002141913.USD","LU0820561909.HKD","LU0158827948.USD","LU1061106388.HKD","LU1267930490.SGD","LU1989772840.SGD","IE00BBT3K403.USD","LU0098860793.USD","SG9999015986.USD","LU0868494617.USD","LU1093756168.USD","IE000BZT7R73.USD","LU0310799852.SGD","LU0234570918.USD","TRUH","LU2237443465.HKD","LU2089984988.USD","LU0203345920.USD","LU0432979614.USD","LU0949170772.SGD","LU1934455863.HKD","LU1496350502.SGD","IE00BLSP4239.USD","IE00BVYPNW00.USD","LU0170899867.USD","LU1057294990.SGD","LU1983299246.USD","BK4534","JDOC","IE00BJJMRZ35.SGD","SG9999015978.USD","IE00BGHQF631.EUR","LU0965509101.SGD","IE00BLSP4452.SGD","LU0057025933.USD","LU1093756325.SGD","LU0289961442.SGD","LU0708994859.HKD","LU0256863902.USD","LU0689472784.USD","LU0820561818.USD","LU1003077747.HKD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0965508806.USD","LU1718418525.SGD","LU1430594728.SGD","MEDX","IXJ","AGNG","LU0942090050.USD","SG9999011175.SGD","GLAM","LU0985320562.USD","IE000WAW04H5.SGD","LU1244550494.USD","SG9999015952.SGD","FHLC","SG9999003800.SGD","LU0661504455.SGD","LU0320765646.SGD","LU0965509283.SGD","LU2089284900.SGD","LU1923622614.USD","LU2237443622.USD","IYH","BK4588","LU0256863811.USD","LU2125909593.SGD","LU2237443549.SGD","LU1551013425.SGD","PPH","IE0000B7K699.USD","LU2023251221.USD","LU1074936037.SGD","LU0124676726.USD","IE00B4R5TH58.HKD","BK4550","LU0114720955.EUR","LU1934455194.USD","IE00BN8TJ469.HKD","BK4559","LU0122379950.USD","RXL","IE00BDGV0183.EUR","BK4139","LU0726765562.USD","LU1934455277.USD","LU0943347566.SGD","LU1037948897.HKD","VHT","LU2089283258.USD","LU2237443895.HKD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1670627923.USD","LU2237443978.SGD","LU1037948541.HKD","LU0289739699.SGD","IE00B3PB1722.GBP","LU1585245621.USD","LU0310800379.SGD","LU2357627491.SGD","LU1244550221.USD","LU0882574055.USD","LU2468319806.SGD","IE000F7OJYX1.SGD","LU1989772923.USD","LU0417517546.SGD","LU0868494708.USD","LU0823416689.USD","LU0511384066.AUD","LU0234572021.USD","XLV","LU0472753341.HKD","PJP","LU0203347892.USD","LU0395794307.EUR","BK4585","LU0795875169.SGD","LU1839511570.USD","LU0211327993.USD","IE00B42XCP33.USD","LU2125909247.SGD","LU1023059063.AUD","LU2129689605.HKD","BK4566","LU0029864427.USD","IE00B19Z3B42.SGD","LU1162221912.USD","LU0689626769.HKD","LU1732799900.SGD","LU2133065610.SGD","LU2433249047.HKD","LU0289739343.SGD","LU1732800096.USD","LU2347655156.SGD","LU0965509010.AUD","LU0795875086.SGD","LU0859254822.USD","LU0912757837.SGD","IE0002270589.USD","LU0545039389.USD","LU1989771016.USD","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127614771","title":"艾伯维高管透露：第三季度调整后每股收益预计在3.84至3.88美元之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1127614771","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127614771?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:34","pubTimestamp":1785504866,"startTime":"0","endTime":"0","summary":"艾伯维公司高管在电话会议中表示，预计第三季度调整后每股收益将在3.84至3.88美元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","IE000MB6IJN5.SGD","IE0000B7K699.USD","IE0002270589.USD","LU1037948541.HKD","LU2125909247.SGD","LU0795875169.SGD","LU1496350502.SGD","LU0198837287.USD","LU0689472784.USD","LU0861579265.USD","LU0098860793.USD","LU0114720955.EUR","LU0943347566.SGD","LU0472753341.HKD","LU0965509010.AUD","LU1244550221.USD","LU0985320562.USD","LU1244550577.SGD","IXJ","LU0234570918.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU0726765562.USD","SG9999011175.SGD","SG9999015952.SGD","LU0211328371.USD","LU0738911758.USD","IE000F7OJYX1.SGD","FTXH","LU1496350171.SGD","LU1732800096.USD","IYH","AGNG","LU0553294199.USD","IE00BJT1NW94.SGD","LU1162221912.USD","LU0128525929.USD","LU1003077747.HKD","PJP","LU0057025933.USD","IE00BVYPNV92.GBP","LU0661504455.SGD","LU1585245621.USD","LU0689626769.HKD","LU1037948897.HKD","IE000BZT7R73.USD","LU0965509101.SGD","SG9999015978.USD","IE00B19Z3581.USD","BK4585","LU0310799852.SGD","IE00BLSP4239.USD","LU1093756168.USD","LU1093756325.SGD","LU1291159041.SGD","LU0124676726.USD","LU0882574055.USD","LU1244550494.USD","LU0289739343.SGD","LU1923622614.USD","LU0417517546.SGD","LU2237443978.SGD","LU0203347892.USD","LU2133065610.SGD","LU0912757837.SGD","LU1670628061.USD","LU2112291526.USD","IE00B3PB1722.GBP","LU1023059063.AUD","LU1074936037.SGD","LU1934455194.USD","LU0545039389.USD","LU0708994859.HKD","IE00BBT3K403.USD","LU0942090050.USD","LU1267930573.SGD","LU0868494617.USD","BK4559","BK4550","IE00BVYPNW00.USD","BK4566","LU1929549753.HKD","LU2237443895.HKD","LU0158827948.USD","LU2237443382.USD","LU2087621335.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1551013425.SGD","LU1989772923.USD","LU0289961442.SGD","IE000WAW04H5.SGD","LU1934455277.USD","SG9999003800.SGD","LU0511384066.AUD","IE0009355771.USD","IE00B2B36J28.USD","LU2089283258.USD","LU1989771016.USD","LU2089284900.SGD","LU1430594728.SGD","BK4534","LU1267930490.SGD","TRUH","GLAM","MEDX","LU0256863902.USD","LU2357627491.SGD","LU1670627923.USD","LU0203345920.USD","FHLC","LU1989772840.SGD","BK4139","LU1718418525.SGD","LU2347655073.USD","JDOC","LU0310800379.SGD","LU0432979614.USD","LU0820561909.HKD","LU0122379950.USD","BK4581","IE0002141913.USD","LU0795875086.SGD","SG9999015986.USD","IE00BDGV0183.EUR","IE0004445239.USD","LU1934455863.HKD","BK4588","IE00B42XCP33.USD","LU2347655156.SGD","LU2129689605.HKD","LU1057294990.SGD","LU2089984988.USD","BK4533","LU0256863811.USD","LU2129689431.USD","LU2237443549.SGD","IE00BLSP4452.SGD","LU2125909593.SGD","IE00BN8TJ469.HKD","LU2023251221.USD","LU2129689514.USD","LU1983299246.USD","LU2237443622.USD","IE00BGHQF631.EUR","LU2433249047.HKD","LU0320765646.SGD","LU0456855351.SGD","LU1551013342.USD","RXL","IE000SO60NU8.SGD","IE00B19Z3B42.SGD","LU0069063385.USD","LU0859254822.USD","LU1839511570.USD","LU0211327993.USD","XLV","PPH","IE00BJJMRZ35.SGD","LU0868494708.USD","LU0820561818.USD","LU0949170772.SGD","LU0823416689.USD","LU2237443465.HKD","LU0395794307.EUR","SG9999015945.SGD","ABBV","SG9999001440.SGD","LU1061106388.HKD","LU0965508806.USD","LU0965509283.SGD","LU0170899867.USD","VHT","LU0058720904.USD","LU0289739699.SGD","LU2468319806.SGD","LU1732799900.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161700508","title":"艾伯维高管透露：全年净营收预期上调至约676亿美元，较此前预测增加3亿美元——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1161700508","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161700508?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:28","pubTimestamp":1785504492,"startTime":"0","endTime":"0","summary":"艾伯维公司高管在电话会议中表示，目前预计全年总净营收将达到约676亿美元。这一数字相较于此前预测，上调了整整3亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU2433249047.HKD","IE0009355771.USD","LU0882574055.USD","IE00B19Z3B42.SGD","LU2129689514.USD","IE00BVYPNV92.GBP","LU1074936037.SGD","IYH","LU2237443549.SGD","LU1291159041.SGD","LU1162221912.USD","LU1430594728.SGD","PJP","SG9999003800.SGD","IE00B3PB1722.GBP","LU0320765646.SGD","LU2347655156.SGD","LU2125909593.SGD","IE0004445239.USD","IE00BGHQF631.EUR","LU0965509010.AUD","IE00BJT1NW94.SGD","LU0069063385.USD","LU1037948897.HKD","LU1989772840.SGD","LU1551013425.SGD","LU1839511570.USD","BK4550","LU0170899867.USD","LU1244550494.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU0553294199.USD","LU1670627923.USD","LU0395794307.EUR","IE00B19Z3581.USD","LU0128525929.USD","LU0965508806.USD","LU0689472784.USD","LU0029864427.USD","LU1670628061.USD","LU0211328371.USD","IE0002141913.USD","LU0122379950.USD","LU1732799900.SGD","LU2237443622.USD","LU0859254822.USD","FTXH","LU2237443465.HKD","LU2468319806.SGD","LU1496350171.SGD","LU0942090050.USD","LU0795875086.SGD","IE000BZT7R73.USD","LU0310799852.SGD","LU0861579265.USD","IXJ","LU1983299246.USD","LU0868494708.USD","LU0203345920.USD","PPH","LU0057025933.USD","LU1093756325.SGD","LU0985320562.USD","LU1929549753.HKD","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","LU0158827948.USD","LU0738911758.USD","LU2112291526.USD","LU0795875169.SGD","BK4581","BK4588","BK4139","IE000SO60NU8.SGD","LU0689626769.HKD","FHLC","LU0545039389.USD","LU0124676726.USD","LU1989772923.USD","BK4534","LU0820561818.USD","LU0726765562.USD","LU0310800379.SGD","LU1718418525.SGD","LU0234572021.USD","LU2237443895.HKD","IE00BBT3K403.USD","LU1093756168.USD","TRUH","LU2089284900.SGD","LU0417517546.SGD","LU2347655073.USD","LU0432979614.USD","LU0868494617.USD","SG9999015978.USD","IE00B42XCP33.USD","LU1585245621.USD","MEDX","LU1061106388.HKD","SG9999015952.SGD","BK4585","AGNG","LU0256863902.USD","LU2237443978.SGD","SG9999015945.SGD","LU0456855351.SGD","LU1057294990.SGD","LU1732800096.USD","LU0289961442.SGD","LU1934455194.USD","LU0198837287.USD","IE00BDGV0183.EUR","LU0511384066.AUD","JDOC","ABBV","LU0289739699.SGD","LU0912757837.SGD","LU0256863811.USD","IE000MB6IJN5.SGD","LU0820561909.HKD","LU1496350502.SGD","XLV","IE00BN8TJ469.HKD","IE00BLSP4239.USD","LU1267930573.SGD","LU1923622614.USD","IE00BVYPNW00.USD","BK4533","LU1003077747.HKD","LU2087621335.USD","LU1551013342.USD","LU2129689431.USD","LU1244550577.SGD","IE00BFTCPJ56.SGD","LU0965509283.SGD","LU0943347566.SGD","LU1989771016.USD","LU0114720955.EUR","IE00BSNM7G36.USD","LU0203347892.USD","LU2089984988.USD","LU0965509101.SGD","LU2237443382.USD","LU1934455277.USD","LU1037948541.HKD","BK4559","IE00BJJMRZ35.SGD","LU1244550221.USD","SG9999011175.SGD","SG9999001440.SGD","LU2089283258.USD","IE000WAW04H5.SGD","LU2129689605.HKD","LU2133065610.SGD","LU0661504455.SGD","LU0234570918.USD","LU0472753341.HKD","IE0000B7K699.USD","LU1934455863.HKD","LU0708994859.HKD","SG9999015986.USD","LU0058720904.USD","IE00B2B36J28.USD","LU0289739343.SGD","BK4566","LU1267930490.SGD","LU0098860793.USD","LU2357627491.SGD","LU2125909247.SGD","GLAM","LU0949170772.SGD","LU1023059063.AUD","LU0211327993.USD","VHT","LU0823416689.USD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177080903","title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1177080903","media":"老虎资讯综合","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177080903?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:18","pubTimestamp":1785500326,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘前跌近4%，报247.52美元。消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120758809","title":"异动解读｜艾伯维公司盘前下跌4.29%，Q2业绩超预期但收购摊薄压制全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1120758809","media":"行情直击","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120758809?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:53","pubTimestamp":1785498788,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘前下跌4.29%，报250.0美元/股，成交额202.1万美元。消息面上，公司发布第二季度财报，调整后每股收益3.65美元，超市场预期的3.60美元；营收169.90亿美元，超预期的167.65亿美元，同比增幅显著。此前公司股价在多重利好推动下已累计大幅上涨，巴克莱等多家机构上调目标价，市场对财报预期充分定价，业绩兑现后获利回吐压力明显。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158299319","title":"艾伯维：2026财年调整后每股收益指引包含收购Apogee Therapeutics带来的每股0.14美元摊薄影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1158299319","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158299319?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:48","pubTimestamp":1785498494,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）近日披露，其2026财年调整后的每股收益（EPS）指引中，已纳入了因收购Apogee Therapeutics而产生的每股约0.14美元的摊薄效应。这一财务影响，直接在预期利润数据中体现，显示出公司对近期并购交易成本进行的前瞻性评估。通过此次收购，艾伯维正积极推进其战略布局，但短期内，该交易将对每股收益构成一定压力。市场分析师正密切关注这一指引，以评估其对公司未来盈利能力的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","PJP","LU2129689514.USD","LU1267930573.SGD","LU1989771016.USD","LU0170899867.USD","LU0965509010.AUD","LU1074936037.SGD","LU0823416689.USD","LU1551013342.USD","LU1291159041.SGD","LU2112291526.USD","SG9999003800.SGD","IE00B2B36J28.USD","FTXH","LU1732800096.USD","LU2089283258.USD","LU0310800379.SGD","LU1732799900.SGD","LU0965509101.SGD","LU0708994859.HKD","IE00B42XCP33.USD","LU1989772840.SGD","SG9999015986.USD","IE00BGHQF631.EUR","JDOC","LU1670627923.USD","LU1003077747.HKD","LU0198837287.USD","IE00BLSP4239.USD","BK4139","LU0058720904.USD","LU1989772923.USD","LU2237443978.SGD","BK4585","LU0861579265.USD","BK4534","LU2089284900.SGD","LU0689472784.USD","LU1983299246.USD","LU2357627491.SGD","BK4588","LU0689626769.HKD","LU0985320562.USD","LU1093756168.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU2433249047.HKD","IE0002270589.USD","LU0868494708.USD","LU1585245621.USD","LU1244550577.SGD","LU0545039389.USD","IE000BZT7R73.USD","LU1934455863.HKD","LU1037948897.HKD","XLV","IE00B19Z3B42.SGD","LU0114720955.EUR","ABBV","GLAM","IE000F7OJYX1.SGD","LU1267930490.SGD","IE0009355771.USD","IE0002141913.USD","IE00BDGV0183.EUR","LU0098860793.USD","LU0122379950.USD","IE000WAW04H5.SGD","LU0965509283.SGD","IXJ","BK4581","LU1057294990.SGD","IE0000B7K699.USD","LU1839511570.USD","LU0289739699.SGD","LU0320765646.SGD","LU1037948541.HKD","LU1496350171.SGD","LU0211327993.USD","LU0057025933.USD","LU0417517546.SGD","LU2237443382.USD","LU0456855351.SGD","LU0472753341.HKD","LU0859254822.USD","LU2468319806.SGD","LU0029864427.USD","LU2237443895.HKD","IE00BN8TJ469.HKD","SG9999015945.SGD","IE00BJT1NW94.SGD","LU2237443465.HKD","PPH","LU2125909247.SGD","LU0395794307.EUR","AGNG","IYH","LU0942090050.USD","LU1061106388.HKD","VHT","LU0882574055.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","SG9999011175.SGD","RXL","BK4566","LU0553294199.USD","LU1934455277.USD","IE00BVYPNV92.GBP","LU2347655156.SGD","MEDX","LU2133065610.SGD","LU1551013425.SGD","LU0820561818.USD","LU0795875169.SGD","IE00BLSP4452.SGD","LU0432979614.USD","LU0661504455.SGD","IE000SO60NU8.SGD","LU1929549753.HKD","LU1923622614.USD","LU2347655073.USD","LU1162221912.USD","SG9999015978.USD","LU0256863811.USD","LU0738911758.USD","LU0289961442.SGD","LU2129689431.USD","IE00B3PB1722.GBP","TRUH","LU0943347566.SGD","LU0726765562.USD","LU2087621335.USD","LU1244550221.USD","LU0795875086.SGD","IE0004445239.USD","LU1023059063.AUD","LU1093756325.SGD","LU0289739343.SGD","LU0211328371.USD","SG9999015952.SGD","LU0069063385.USD","BK4559","LU0310799852.SGD","LU0820561909.HKD","IE00BBT3K403.USD","LU0949170772.SGD","LU0234570918.USD","IE00BVYPNW00.USD","LU2237443622.USD","BK4533","IE000MB6IJN5.SGD","LU0912757837.SGD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2125909593.SGD","LU0203345920.USD","FHLC","BK4550","LU1430594728.SGD","LU0256863902.USD","IE00B19Z3581.USD","LU0128525929.USD","LU1718418525.SGD","LU1934455194.USD","LU0511384066.AUD","LU0158827948.USD","LU1496350502.SGD","LU1670628061.USD","LU2129689605.HKD","LU0203347892.USD","LU1244550494.USD","LU2089984988.USD","IE00B4R5TH58.HKD","LU0965508806.USD","LU2023251221.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191974640","title":"艾伯维公司：第二季度业绩受收购IPR&D及里程碑费用影响，每股收益减少0.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191974640","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191974640?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:48","pubTimestamp":1785498491,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）公布的第二季度财报显示，因收购过程中的在研项目（IPR&D）及里程碑费用支出，其每股收益遭遇了0.17美元的不利冲击。这一财务指标的下滑，主要源于相关并购活动产生的成本摊销。具体来看，这些费用直接拖累了公司本季度的盈利表现，使得每股收益数据承压。尽管面临此类短期财务挑战，但公司整体运营仍保持稳健。市场分析人士指出，此类一次性支出虽会影响短期业绩，但却是公司长期战略布局中不可或缺的一部分，旨在通过外部研发合作和里程碑式进展来巩固未来增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0511384066.AUD","LU0320765646.SGD","LU0912757837.SGD","IE00B2B36J28.USD","BK4550","MEDX","LU0310800379.SGD","LU1291159041.SGD","LU0545039389.USD","BK4534","LU2089284900.SGD","IE00BJJMRZ35.SGD","LU1839511570.USD","LU1934455277.USD","LU1934455863.HKD","AGNG","RXL","LU2023251221.USD","LU0069063385.USD","LU1074936037.SGD","LU1732800096.USD","LU0868494617.USD","LU0820561818.USD","LU1551013342.USD","IE00BVYPNW00.USD","LU1267930490.SGD","LU0256863811.USD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU1989772923.USD","FTXH","LU0029864427.USD","LU0128525929.USD","LU0942090050.USD","IE00BDGV0183.EUR","BK4588","LU1244550494.USD","LU0198837287.USD","LU0124676726.USD","IE00BJT1NW94.SGD","IE00B42XCP33.USD","LU0417517546.SGD","LU0965509283.SGD","LU1057294990.SGD","LU0965509101.SGD","LU0689626769.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU2347655156.SGD","ABBV","PJP","LU0057025933.USD","BK4581","LU0289739699.SGD","LU2089984988.USD","LU0234572021.USD","SG9999015978.USD","PPH","LU0795875086.SGD","LU0114720955.EUR","LU1923622614.USD","LU0211327993.USD","LU0738911758.USD","LU0868494708.USD","LU1496350171.SGD","LU0310799852.SGD","LU2133065610.SGD","LU0203347892.USD","LU2087621335.USD","SG9999001440.SGD","IE00BN8TJ469.HKD","SG9999015952.SGD","LU0170899867.USD","LU0965508806.USD","LU2125909247.SGD","LU1023059063.AUD","LU1670627923.USD","SG9999003800.SGD","TRUH","LU0859254822.USD","LU0256863902.USD","LU1430594728.SGD","LU1551013425.SGD","LU1496350502.SGD","JDOC","LU1162221912.USD","LU0820561909.HKD","XLV","LU1718418525.SGD","LU1267930573.SGD","IE0002270589.USD","IE00BVYPNV92.GBP","LU0432979614.USD","LU0661504455.SGD","LU1037948897.HKD","LU0472753341.HKD","LU1934455194.USD","LU2089283258.USD","LU0553294199.USD","LU2129689431.USD","IXJ","LU1989771016.USD","IE000MB6IJN5.SGD","LU2237443895.HKD","LU0122379950.USD","IE0009355771.USD","LU1037948541.HKD","SG9999011175.SGD","LU0708994859.HKD","LU0098860793.USD","LU0289739343.SGD","LU1003077747.HKD","LU0456855351.SGD","LU2129689514.USD","IE00BSNM7G36.USD","LU0985320562.USD","IE00B4R5TH58.HKD","SG9999015986.USD","LU0395794307.EUR","IE0000B7K699.USD","LU1093756325.SGD","LU0943347566.SGD","IE0002141913.USD","IE000SO60NU8.SGD","LU0949170772.SGD","LU1929549753.HKD","IE000WAW04H5.SGD","LU1989772840.SGD","LU0234570918.USD","LU1093756168.USD","LU0203345920.USD","LU0795875169.SGD","LU0965509010.AUD","LU2357627491.SGD","LU2112291526.USD","LU2237443978.SGD","GLAM","LU2347655073.USD","LU1670628061.USD","LU0882574055.USD","LU2468319806.SGD","LU0689472784.USD","BK4139","LU1585245621.USD","IE0004445239.USD","LU1244550577.SGD","LU0726765562.USD","SG9999015945.SGD","LU0211328371.USD","LU2237443549.SGD","FHLC","IE00BBT3K403.USD","LU0861579265.USD","IE00BLSP4452.SGD","LU1061106388.HKD","LU2125909593.SGD","LU0823416689.USD","LU0289961442.SGD","VHT","LU2237443382.USD","BK4559","IE00BFTCPJ56.SGD","LU2237443622.USD","LU1244550221.USD","LU1732799900.SGD","IE00B3PB1722.GBP","LU2237443465.HKD","LU0058720904.USD","LU1983299246.USD","LU0158827948.USD","BK4533","LU2129689605.HKD","LU2433249047.HKD","IYH","BK4566","IE000BZT7R73.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121244940","title":"异动解读｜艾伯维公司盘中下跌3.15%，生物科技板块普跌叠加财报发布前夕承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1121244940","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121244940?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:57","pubTimestamp":1785423426,"startTime":"0","endTime":"0","summary":"7月30日，艾伯维公司盘中下跌3.15%，报255.805美元/股，成交额3.42亿美元。当日生物科技板块普遍走弱，行业内阿尔尼拉姆制药大跌逾26%，Madrigal跌超12%，吉利德科学跌超2%，安进跌近2%，板块抛压明显。公司将于7月31日发布第二季度财报，市场预期营收约167.60亿美元，同比增长11.54%，调整后每股收益3.57至3.61美元，同比增超24%。在连续利好推升股价后，财报发布前夕板块整体回调，公司股价随之承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":0.0417},{"period":"3month","weight":0.1286},{"period":"6month","weight":0.1145},{"period":"1year","weight":0.204},{"period":"ytd","weight":0.1224}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.5,"avgChangeRate":0.011241},{"month":8,"riseRate":0.571429,"avgChangeRate":0.008439},{"month":9,"riseRate":0.571429,"avgChangeRate":0.013885},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}